Goh, L. L., Lee, Y., Tan, E. S., Lim, J. S. C., Lim, C. W., & Dalan, R. (2018). Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: A case report. BMC Med Genomics.
استشهاد بنمط شيكاغوGoh, Liuh Ling, Yingshan Lee, Ee Shien Tan, James Soon Chuan Lim, Chia Wei Lim, و Rinkoo Dalan. "Patient With Multiple Acyl-CoA Dehydrogenase Deficiency Disease and ETFDH Mutations Benefits From Riboflavin Therapy: A Case Report." BMC Med Genomics 2018.
MLA استشهادGoh, Liuh Ling, et al. "Patient With Multiple Acyl-CoA Dehydrogenase Deficiency Disease and ETFDH Mutations Benefits From Riboflavin Therapy: A Case Report." BMC Med Genomics 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.